Table of Contents Table of Contents
Previous Page  970 / 1096 Next Page
Information
Show Menu
Previous Page 970 / 1096 Next Page
Page Background

S954

ESTRO 36

_______________________________________________________________________________________________

comparison of planned to delivered plans for all TG-119

targets for IMRT and VMAT deliveries are shown in Figures

1 and 2 below, and for the two MLC systems. The

prototype MLC system produced higher passing rates for

both IMRT and VMAT than the TB MLC system for the

various test plans. In addition, the prototype MLC system

performs equally well for IMRT and VMAT, whereas the TB

MLC is less optimum for VMAT delivery compared to IMRT

(Fig. 1 and Fig. 2).

Conclusion

The TG-119 test plans were performed on a prototype MLC

system in comparison to the well-understood TB

Millennium MLC. Our investigation showed, in the context

of TG-119, this prototype MLC performs well for both IMRT

and VMAT plans.

1

Ezzel G., et al., 'IMRT commissioning: Multiple institution

planning and dosimetry comparisons, a report from AAPM

Task Group 119.” Med. Phys.

36

:5359-5373 (2009).

EP-1735 Total skin irradiation with helical

Tomotherapy: Planning and dosimetry feasibility

aspects

A. Haraldsson

1

, P. Engström

1

1

Skåne University Hospital, Radiation physics, Lund,

Sweden

Purpose or Objective

Mycosis fungoides (MF) is a lymhpatic disease that attacks

the skin. The primary treatment for treating MF is total

skin electron therapy (TSET). The procedure is technically

challenging both in terms of dosimetry and treatment

delivery. Helical TomoTherapy (HT) is due to its design

especially advantageous when irradiating very long and

complex targets. In this study we have explored the

possibility of employing HT in the treatment of total skin

irradiation (TSI).

Material and Methods

We used an anthropomorphic whole body phantom (PBU-

60 Kyoto Kaguka). The phantom was immobilized with

whole body vacuum bag, a five-point open head net mask

fixated to the couch and an individual neck rest. The

phantom was covered with a 7 mm thick wet suit made of

Neoprene (AquaLung) and CT scanned in two sets; from

vertex to thigh and from toes to hip. The CTV was defined

as skin with 5mm depth, with PTV as a 7 mm expansion.

An optimization bolus was added from the body and 12 mm

expansion, defined as mass density 1.0 g/cm

3

. The

prescribed dose was 12 Gy delivered in 6 fractions. The

dose planning was aimed to keep D

95%

> 95% to PTV and

minimizing dose to organs at risk, which was defined as

the rest of the body. An optimization structure was used

to create a tangential irradiation of the skin, minimizing

the dose to normal tissue. We tested the bolus effect of

Neoprene with Gafchromic EBT3 film by irradiating slabs

of 7mm, dry and soaked in water. To verify skin doses, the

phantom with wet suit was irradiated with several 2x2 cm

2

slabs of film taped to the body. The film were evaluated

at least 24 hours after irradiation. Corresponding detector

array measurements (Delta4, Scandidos) were done and

evaluated with gamma analysis. Further, a robustness test

was done by moving the phantom 10 mm in the x, y and z

directions, to evaluate the effect of mispositioning.

Results

Results of planning and robustness tests are presented in

table 1. Measured data fit to depth dose data yields a dose

maximum at 28 mm for Neoprene. Hence, 7 mm is

equivalent to 3 mm thick water bolus and lightly soaked

Neoprene adds another 1.2 mm thickness of water. Delta4

gamma analysis with 2 mm and 3%, global dose, is clinical

acceptable with regards to deliverability (M = 93%, SD =

3%). The verification of 27 film slabs for skin dose gave an

average difference from TPS dose of 4% (SD = 3%), figure

1.

Conclusion

The difference of measured dose compared to TPS, for

both film and Delta4 dosimetry is larger than most types

of targets treated with HT which is to be expected

considering the technique and size of target. The

deliverability is within limit of our clinic action levels

(gamma pass rate < 90%) and neoprene is feasible as bolus.

The benefits, in comparison with reported electron

treatments, are target homogeneity and target coverage

with good immobilization and complete irradiation with

two positions. The higher dose to organs at risk than

reported with electrons needs to be addressed if

acceptable with regards to toxicity.